We recently engaged in a cooperative study of 765 patients with asymptomatic neurosyphilis, 50 per cent. of whom were followed for 3 years, 25 per cent. for 5 years, and 20 per cent. for more than 5 years. As shown in Fig. 1 , penicillin is remarkably effective in preventing clinical progression when given for asymptomatic neurosyphilis; only 3 per cent. of such patients had developed any objective evidence of neurosyphilis (in all cases minor) by the seventh year after treatment. For comparison, there is also shown the probability of developing clinical neurosyphilis among 467 patients with asymptomatic neurosyphilis treated predominantly by metal chemotherapy. In the penicillin group, progression had practically ceased after the third year of observation, but after metal chemotherapy it continued to increase with increasing observation periods. The recorded progressions among the 765 patients treated with penicillin were objective rather than subjective, never disabling, and frequently questionable. Neither tabes nor primary optic atrophy, nor *
For many years, dating back to about 1930, neurosyphilis in general and primary optic atrophy of syphilitic origin in particular have been the subjects of special interest and repeated study in the Syphilis Division of the Department of Medicine and the Department of Ophthalmology of the Johns Hopkins Hospital. As to optic atrophy, Moore, Woods, and myself are responsible for the concepts and data upon which the following remarks are based.
Prevention of Neurosyphilis in General, and of Tabes and Optic Atrophy in Particular.-Clinical neurosyphilis has not yet been observed to develop following the penicillin treatment of early (primary or secondary) syphilis. Penicillin is of equal preventive value when given for so-called asymptomatic neurosyphilis manifested by abnormal spinal fluids, in the absence of signs or symptoms of neurosyphilis. (Hahn, Cutler, Curtis, and nine others, 1956 ).
We recently engaged in a cooperative study of 765 patients with asymptomatic neurosyphilis, 50 per cent. of whom were followed for 3 years, 25 per cent. for 5 years, and 20 per cent. for more than 5 years. As shown in Fig. 1 , penicillin is remarkably effective in preventing clinical progression when given for asymptomatic neurosyphilis; only 3 per cent. of such patients had developed any objective evidence of neurosyphilis (in all cases minor) by the seventh year after treatment. For comparison, there is also shown the probability of developing clinical neurosyphilis among 467 patients with asymptomatic neurosyphilis treated predominantly by metal chemotherapy. In the penicillin group, progression had practically ceased after the third year of observation, but after metal chemotherapy it continued to increase with increasing observation periods. The recorded progressions among the 765 patients treated with penicillin were objective rather than subjective, never disabling, and frequently question- Hahn and others, 1956 ).
indeed any form of parenchymatous neurosyphilis, was observed to develop. Pathology of Primary Optic Atrophy.-This has been studied for many years, but there are still gaps in our knowledge. There is general agreement that the process begins in the intracranial portion of the optic nerve distal to the chiasma. The degeneration usually occurs first in the marginal fibres of the nerve, and there is thickening and perivascular round-cell infiltration of the overlying membranes, especially the pia, and of the connective tissue septa of the nerve. There is, however, no agreement as to the important question of Clinical Picture.-This is so well known that it requires but brief mention, although it should be emphasized that, on ophthalmoscopic examination alone, it is impossible to differentiate the atrophy of central nervous system syphilis from that caused by certain brain tumours, intracranial aneurysms, arteriosclerosis, often disseminated sclerosis, and sometimes toxic amblyopias, and occasionally from the optic atrophy of glaucoma and thrombosis of the central retinal artery.
Pupillary changes are, however, almost constant in the syphilitic type. The media are clear, the disks normally being outlined with preservation of the physiologic cups. There is a gradually developing bluish-white pallor Qf the nerve, which usually involves the whole of it, sometimes with accentuation of atrophy in the papillo-macular bundle. There are no associated retinal or choroidal lesions and, if such are present, they are only coincidental. In advanced cases, there is some constriction of the arteries, probably due to the secondary fibrosis of the nerve itself with resulting traction on the central vessels. The end picture is advanced generalized pallor of the nerve without visible ophthalmoscopic evidence of active or old inflammation.
The failure of visual acuity may occur early or late according to whether there is early degeneration of the papillo-macular bundle, or degeneration beginning in the peripheral fibres and slowly progressing centrally (Fig. 2 (Fig. 7) . It is unlikely that any significant alteration in these figures, based upon 252 person-years of retrospective analysis, will result from any further study. Nevertheless, it is manifestly not a sound device to compare the observed course after treatment with historical data concerning the estimated course before observation and treatment, since the two sets of data are not comparable. The former is objective, while the latter is subjective and is influenced by a multiplicity of extraneous factors, including the care with which the history is taken, the accuracy of the patient's memory, unilateral onset in which one eye may become completely blind before the other is significantly involved (hence the patient may be unaware that he has only monocular vision), and the type of visual-field defect. A.central scotoma obviously precipitates subjective symptoms of visual failure earlier than a slowly developing concentric constriction of the visual fields. In the analyses of individual case records, it was repeatedly noted that the elicited date of onset of symptoms varied from examiner to examiner.
For purposes of objectivity, in our most recent study (Hahn, Zellmann, Naquin, Cross, and Marcus, 1955) The "no-treatment" group was in fact a heterogeneous one, in which the patients had largely been treated elsewhere by various methods; thus it did not constitute a true untreated control group. The other groups were largely mutually exclusive, even considering previous treatment before our first observation.
Comparison of different treatment methods is best made when they are as nearly concurrent in time as possible. The present material falls far short of this ideal. The patients in Group 2 (metal chemotherapy) were all first observed between 1920 and 1943. The majority of those in Group 3 (malaria without penicillin) also belonged to this period, the remainder being scattered up to 1948. Group 4 (malaria plus penicillin) and Group 5 (penicillin alone) were, of course, first observed from 1943 onwards.
The treatment groups were similar with respect to neurological diagnosis, degree of pre-treatment visual field constriction, percentage of inactive spinal fluids with normal cell count and protein, and apparent rate of progression as judged by scatter charts before our first treatment.
However, they were not strictly comparable in respect of age. Those patients given malaria were predominantly younger than those patients treated by other methods. With regard to race, there were striking dissimilarities between the basic treatment groups. Malaria without penicillin was given in a ratio of almost 3 : 1 to whites; penicillin without malaria was given in a ratio of over 3 : 1 to Negroes; in the other treatment groups the ratio approached 1: 1. Another difference of considerable importance is that, by and large, those patients given penicillin alone had the symptoms longer and had somewhat lower visual efficiency on admission to the study than did patients in the other treatment groups.
Another and extremely important difference between these groups was in the percentage of patients in each who returned for follow-up. The "treated elsewhere, no treatment at Johns Hopkins Hospital"' group were so poorly followed as to preclude any attempt at determining the results. The percentage of patients followed was poQr for the metal-treated group and relatively good for the more recently treated malaria, malaria plus penicillin, and penicillin groups. This difference in degree of follow-up introduces yet another serious bias in comparing the treatment groups, particularly those treated with metals and those given penicillin, malaria, or both. Since only 56 per cent. of the metal-treated group returned for second observation, any such comparison necessitates the large assumption that the results in the 44 per cent. who were not followed were similar to the 56 per cent. who were followed.
Despite these many differences in basic data between the treatment groups, we have thought it worth while to determine the outcome in order to present the picture of the rate of progression of primary optic atrophy under actual observation after treatment, and because, in spite of its many deficiencies, th'e present material is the best available in the literature thus far. Moreover, in view of the decreasing incidence of syphilis, it seems unlikely that better material will become available in the foreseeable future. Fig. 8 (overleaf) shows the cumulative probability of losing 10 per cent. or more of initial visual efficiency according to the type of treatment received. The actual life-tables upon which this and subsequent figures are based are not shown, but, in general, calculations were terminated when only one-third of the patients remained under observation. There are no striking differences in outcome between the basic treatment groups. The one conclusion which may be drawn is that in a high proportion of cases no form of treatment seems able to arrest progression. In the various treatment groups, the rate of progression 3 years after treatment was from 50 to 70 per cent. of the patients Fig. 9 shows the cumulative probability of losing 80 per cent. or more of initial visual efficiency according to the type of treatment received. Again the differences between treatment groups do not appear to be significant. Fig. 9 is of interest, however, in that it gives an entirely different picture of the prognosis of syphilitic optic atrophy under direct observation as compared with that derived from questioning already blind patients about the duration of their symptoms (cf. Fig. 7) . Moreover, the configuration of the curves, with their lack of late rise and their flattening out after the first few years, suggests that, with treatment, the prognosis for prolonged retention of some useful vision, even at a low level, is relatively good. The patients treated with metals or with malaria alone were followed the longest, and even 10 to 11 years after treatment, only 21 (Fig. 12, opposite) .
Likewise, a loss of 80 per cent. or more of initial visual efficiency, even as long as 10 to 11 years after the first observation, occurred in only 9 per cent. of those with relatively good visual efficiency as compared with 26 per cent. of those with more advanced visual failure (Fig. 13, opposite) .
In order to present a composite picture of the course of treated syphilitic primary optic atrophy, there is shown the cumulative probability of losing 10 per cent. or more and also 80 per cent. or more of initial visual efficiency in 141 patients after various types of treatment (Fig. 14, see 
